BIOLIFE SOLUTIONS INC (BLFS) Stock Analyst Ratings
USA - NASDAQ:BLFS - US09062W2044 - Common Stock
27.87 USD
+0.97 (+3.61%)
28.5 USD
+0.63 (+2.26%)
ChartMill assigns a Buy % Consensus number of 84% to BLFS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.93. This target is 14.55% above the current price.
BLFS was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BLFS.
In the previous month the buy percentage consensus was at a similar level.
BLFS was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-08 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-12-19 | Benchmark | Reiterate | Buy -> Buy |
| 2024-12-13 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-13 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-13 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-09 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-07-17 | TD Cowen | Maintains | Buy -> Buy |
| 2024-05-13 | Benchmark | Upgrade | Hold -> Buy |
| 2024-04-04 | Jefferies | Initiate | Buy |
| 2023-08-10 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023-08-09 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-09 | Lake Street | Maintains | Buy -> Buy |
| 2023-07-17 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-07-11 | Craig-Hallum | Initiate | Buy |
| 2023-03-17 | Stephens & Co. | Maintains | Overweight |
| 2023-03-06 | Oppenheimer | Reiterate | Outperform |
| 2022-05-10 | Keybanc | Maintains | Overweight |
| 2022-05-10 | Stephens & Co. | Maintains | Overweight |
| 2022-04-25 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-08-13 | Keybanc | Maintains | Overweight |
| 2021-05-14 | Benchmark | Downgrade | Buy -> Hold |
| 2021-03-23 | Keybanc | Maintains | Overweight |
| 2021-03-23 | Benchmark | Upgrade | Hold -> Buy |
BIOLIFE SOLUTIONS INC / BLFS FAQ
What is the average price target for BIOLIFE SOLUTIONS INC (BLFS) stock?
16 analysts have analysed BLFS and the average price target is 31.93 USD. This implies a price increase of 14.55% is expected in the next year compared to the current price of 27.87.
What is the consensus rating for BLFS stock?
The consensus rating for BIOLIFE SOLUTIONS INC (BLFS) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed BIOLIFE SOLUTIONS INC (BLFS)?
The number of analysts covering BIOLIFE SOLUTIONS INC (BLFS) is 16.